301257.SZ
SMO ClinPlus Co., Ltd.
SZSE · M 科研服务 · CN
CNY 45.22
−6.80%Margins
Gross margin
25.7%
EBITDA margin
15.7%
EBIT margin
15.4%
Net margin
13.3%
FCF margin
3.7%
8.9%
Return on equity
7.5%
Return on assets
10.4%
Return on invested capital
0.56x
Asset turnover
CNY 40.2M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026